Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
April 16, 2014, 02:10:25 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 619745
  • Total Topics: 46684
  • Online Today: 196
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Recently discovered T memory stem cells may be long-term viral reservoir  (Read 833 times)

0 Members and 1 Guest are viewing this topic.

Offline Tadeys

  • Member
  • Posts: 159
IV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Now, investigators from the Harvard-affiliated Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT, and Harvard may have found HIV’s viral hiding place — in a small group of recently identified T cells with stem cell-like properties.

“Most human cells are short-lived, so it has been unclear how HIV manages to stick around for decades in spite of very effective antiviral treatment,” said Mathias Lichterfeld of the MGH Infectious Disease Division, an assistant professor at Harvard Medical School and corresponding author of a report on the findings receiving advance online publication in Nature Medicine.

Though HIV normally attacks immune system cells called T cells, those cells are short-lived. The virus’ ability to survive years of therapy caused researchers to wonder whether it might also infect stem cells, regenerative cells that are the longest-lasting in the body, Lichterfeld said. The problem with that idea is that organ-specific stem cells are resistant to HIV infection.

“We have discovered that a new group of T cells, called T memory stem cells, are susceptible to HIV and likely represent the longest-lasting cellular niche for the virus,” Lichterfeld said.

HIV’s devastating impact on the human immune system is due to its habit of infecting the CD4-positive T cells that direct and support the infection-fighting activities of other immune cells. Subtypes of CD4 T cells have different functions and all are capable of being infected by HIV.

With antiviral treatment, drugs keep the virus in infected cells from replicating; because most CD4 T cells are short-lived, they die relatively soon. CD4 T memory stem cells, however, can live for decades, and give rise to several types of T cells. This means HIV-infected T memory stem cells could continuously regenerate new HIV-infected cells, fueling HIV persistence in the body.

The MGH/Ragon team found that T memory stem cells express both CD4 and CCR5 — the receptor proteins HIV uses to enter cells — suggesting that these long-lived cells could be the much-sought HIV reservoir. They then found that thesecells can be readily infected with HIV, which was unexpected because traditional stem cells resist HIV infection. Importantly, the investigators found that levels of HIV DNA in patients receiving long-term antiviral treatment were highest in T memory stem cells.

Blood samples taken from patients soon after initial infection and several years later revealed that the viral sequences found in T memory stem cells after six to 10 years of treatment were similar to those found in circulating T cells soon after infection, indicating that HIV had persisted relatively unchanged in T memory stemcells. In addition, the amount of HIV DNA in thesecells remained relatively stable over time, even after long-term treatment caused viral levels to drop in other T cell subsets.

“Our findings suggest that novel, specific interventions will have to be designed to target HIV-infected T memory stem cells,” said Lichterfeld. “Methods of inhibiting stem cell pathways are being studied to eliminate cancer stem cells — persistent cells that are responsible for tumor recurrence after conventional treatments kill proliferating tumor cells. We are now investigating whether any of the drugs that target cancer stem cells might be effective against HIV-infected T memory stem cells.

“Identifying the reservoirs for HIV persistence is a critical step toward developing interventions that could induce a long-term remission without the need for antiviral medication, or possibly eliminate the virus entirely,” he said. “Although a real cure for HIV has been elusive, it is not impossible.”

Maria Buzon of MGH Infectious Diseases and the Ragon Institute is lead author of the Nature Medicine paper. Additional co-authors are Hong Sun, Chun Li, Amy Shaw, Katherine Seiss, Zhengyu Ouyang, Enrique Martin-Gayo, Jin Leng, Florencia Pereyra, Xu Yu, and Bruce Walker, Ragon Institute; Eric Rosenberg, MGH Infectious Diseases Division; Timothy Henrich and Jonathan Li, Brigham and Women’s Hospital; and Ryan Zurakowski, University of Delaware. Walker, the director of the Ragon Institute, is also a Howard Hughes Medical Institute investigator.

http://news.harvard.edu/gazette/story/2014/01/discovering-where-hiv-persists-in-spite-of-treatment/

Offline Mishma

  • Member
  • Posts: 178
    • Marquis de Vauban
Re: Recently discovered T memory stem cells may be long-term viral reservoir
« Reply #1 on: January 17, 2014, 05:40:46 PM »
How does this knowledge jive with the fact that the two HIV+ patients whose immune system's were ablated as part of bone marrow transplants they received (and thought to be "cured" like Timothy Brown) for cancer, are now viremic again? Reinfection, incomplete ablation or other reservoirs? I'm speaking out loud here, (I don't know the answer) but rather than message you personally thought this should be part of the discussion.

2016 CD4 25% UD (less than 20). 27+ years positive. Isentress, Truvada, Acyclovir, Clonazepam, Zolpidem, Bupropion, Lisinopril, Pravastatin, Quetiapine, Doxcycline, Testosterone, Suatriptan/Naproxen, Restasis, Dorzolamide, Latanoprost, Asprin, lortab, Levothyroxine, Fioricet, Restasis, Triamclinolone, Nitrostat.

Offline xinyuan

  • Member
  • Posts: 89
Re: Recently discovered T memory stem cells may be long-term viral reservoir
« Reply #2 on: January 18, 2014, 12:00:07 AM »
In the case of bone marrow transplants, doctors give therapies like radiation and chemotherapy to wipe out the bone marrow. This does not mean they wipe out all immune cells in the body. Immune cells are located everywhere. The gut, the skin, and the lymph system are huge reservoirs that immediately come to mind.

First, medicinal radiation is often focused only on certain parts of the body. If we irradiated the entire body with wild abandon, we create many more problems than solved (think Chernobyl). Imagine your gut sloughing off or your skin frying from too much radiation. So, "incomplete ablation" may be partially true.

Second, chemo has a tendency to hit only cells growing and dividing. It does little to most cells just mucking along (i.e., not dividing) like muscle.

We've known about memory T-cells. The stem cell T-cells are what's new. Long-term T cells aren't actually dividing. And they can migrate. So, they could host HIV but not be caught by the chemo or the radiation. And all it takes is a small number of cells hiding among trillions in the body.

Once these cells start producing virus without ART's, it's just a matter of time for an infection resurgence.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.